ArticleBiomarker research2025

HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia.

Oriol de Barrios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.